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Abstract
The type I transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2), is expressed mainly
in brain and prostate. Expression of TMEFF2 is deregulated in prostate cancer, suggesting a role in this disease, but the
molecular mechanism(s) involved in this effect are not clear. Although androgens promote tmeff2 transcription, androgen
delivery to castrated animals carrying CWR22 xenografts increases TMEFF2 protein levels in the absence of mRNA changes,
suggesting that TMEFF2 may also be post-transcriptionally regulated. Here we show that translation of TMEFF2 is regulated
by androgens. Addition of physiological concentrations of dihydrotestosterone (DHT) to prostate cancer cell lines increases
translation of endogenous TMEFF2 or transfected TMEFF2-Luciferase fusions, and this effect requires the presence of
upstream open reading frames (uORFs) in the 59-untranslated region (59-UTR) of TMEFF2. Using chemical and siRNA
inhibition of the androgen receptor (AR), we show that the androgen effect on TMEFF2 translation is mediated by the AR.
Importantly, DHT also promotes phosphorylation of the a subunit of the translation initiation factor 2 (eIF2a) in an AR-
dependent manner, paralleling the effect on TMEFF2 translation. Moreover, endoplasmic reticulum (ER) stress conditions,
which promote eIF2a phosphorylation, also stimulate TMEFF2 translation. These results indicate that androgen signaling
promotes eIF2a phosphorylation and subsequent translation of TMEFF2 via a mechanism that requires uORFs in the 59-UTR
of TMEFF2.
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Introduction
Androgens signaling through the AR play an essential role in
normal prostate development and contribute to the progression of
prostate cancer. Binding of androgens to the AR promotes
a conformational change that ultimately leads to its translocation
to the nucleus and regulation of transcription of a specific set of
androgen-responsive genes. Clinical and experimental evidence
suggest that prostate cancer progression occurs through alteration
of the normal androgen signaling, reducing the specificity or the
amount of AR ligand required for proliferation and survival [1].
Importantly, recent results indicate that the function of the AR is
specific to the disease stage, triggering a different gene expression
program in androgen-dependent as compared to androgen-
independent prostate cancer [2]. While the role of the AR
signaling axis in transcriptional regulation is well documented,
very little is known regarding its role in translation initiation
proposed in early studies [3,4].
The transmembrane protein with epidermal growth factor and
two follistatin motifs 2 (TMEFF2) is a single pass transmembrane
protein. TMEFF2 is expressed in the embryo [5,6] and selectively
in the adult brain and prostate [7–9]. A role for TMEFF2 in
prostate cancer was suggested by studies indicating that TMEFF2
expression is altered in a significant fraction of primary and
metastatic prostate tumors [5–10]. In addition, we recently
demonstrated that TMEFF2 interacts with sarcosine dehydroge-
nase (SARDH), the enzyme responsible for conversion of sarcosine
to glycine [11]. Importantly, sarcosine was identified as a marker
for prostate cancer progression in a large-scale screen of
metabolites from human prostate samples [12]. Increased plasma
and urine sarcosine levels distinguished prostate cancer from
benign prostate tissue, and were further elevated in metastatic
cancer. In addition, sarcosine metabolism and the enzymes
involved in it (i.e. SARDH) were shown to act as regulators of
cell invasion and metastasis [12]. Therefore, the interaction of
TMEFF2 with SARDH further suggests a role for TMEFF2 in
prostate cancer progression. In fact, we have also established that
full-length TMEFF2 functions as a tumor suppressor and that this
role correlates, at least in part, with its ability to interact with
SARDH and modulate the cellular levels of sarcosine [11].
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In this study we report that translation of TMEFF2 is regulated
by androgens, and this effect requires a functional AR. Results
using xenograft models and prostate cancer cell lines established
that TMEFF2 expression changes in response to androgens and/
or the androgen-dependent or -independent condition of the cells
[8,10]. As demonstrated by Gery et al., [8] these changes are in
part due to transcriptional activation of tmeff2 in response to
androgens. However, increased TMEFF2 protein levels in the
absence of a corresponding increase in mRNA levels have been
observed after addition of androgens to castrated animals carrying
CWR22 xenografts, suggesting that TMEFF2 may also be post-
transcriptionally regulated [10].
The TMEFF2 mRNA has several potential upstream open
reading frames (uORFs) in its leader region, and sequence analysis
suggests that they are well conserved among mammals. Although
only present in 5–10% of the cellular mRNAs, uORFs are
common in the leader regions of mRNAs encoding oncoproteins
or proteins involved in the control of cellular growth and
differentiation, and they function by modulating translation of
these essential genes [13]. After being translated, uORFs generally
block translation of the main downstream coding region by
hampering translation reinitiation at the main translation initiation
codon. However, uORFs can promote selective translation of the
downstream coding region under cellular stress or other conditions
that increase phosphorylation of the a subunit of the eukaryotic
translation initiation factor 2 (eIF2a) [13].
eIF2 in its GTP-bound form is required for the selection of the
translation initiation codon. Phosphorylation of the a subunit of
eIF2 at Ser-51 (eIF2a-P) inhibits the exchange of eIF2-GDP to
eIF2-GTP, preventing recognition of the initiating codon and
decreasing global translation initiation [14]. However, as men-
tioned above, uORF-containing mRNAs are actively translated
under these conditions. Two mechanisms have been proposed to
explain this effect. In the first one, exemplified by the ATF4
mRNA that contains two uORFs, translation reinitiation at the
inhibitory downstream uORF is bypassed under conditions of
eIF2a-P, due to the fact that the lower levels of eIF2-GTP increase
the time required for the scanning ribosomes to re-acquire eIF2-
GTP and reinitiate translation [15]. In the second one, observed in
mRNAs containing a single uORF, scanning ribosomes bypass the
inhibitory uORF due to the reduced efficiency of translation at
initiation codons with a poor Kozak consensus sequence [16]. In
both cases, the uORF bypass results in an increased number of
ribosomes starting translation at the initiation codon of the main
coding sequence, thereby increasing synthesis of that specific
protein.
In this study, we demonstrate that TMEFF2 translation is
regulated by androgens. Androgen-regulation of TMEFF2 trans-
lation requires the presence of the uORFs in the leader region of
the TMEFF2 mRNA and is dependent on eIF2a-P. Further, this
effect is mediated by the AR since it is not observed when AR
levels are reduced by RNAi or the AR antagonist bicalutamide, or
in cell lines that do not express it. These results support a novel
regulatory mechanism of androgen signaling in which uORF-




LNCaP and 22RV1 cells were obtained from American Type
Culture Collection and were maintained in RPMI 1640 (Gibco)
supplemented with either 10% FBS (Gemini Bio-products) or 10%
charcoal-stripped serum (Atlanta Biologicals). PC3 cells (ATCC)
were obtained from Dr. D. Terrian (East Carolina University) and
were also maintained in RPMI 1640. Mouse embryonic fibroblast
expressing the wild type and mutant (Ser51 to Ala) eIF2 were
obtained from Dr. R. Kaufman (Sanford/Burnham Medical
Research Institute) and have been previously described [17].
These cells were grown in DMEM. Dihydrotestosterone, bicalu-
tamide, and actinomycin D were purchased from Sigma-Aldrich.
Constructs and Reporter Assays
PCR mutagenesis was used to mutate the start codons of the
uORFs from AUG to GUG in the TMEFF2 59 UTR. Primers
used for mutagenesis are listed in table 1. The 59 UTRs were
inserted upstream of the Gaussia luciferase gene in the pCMV-
GLuc vector (New England Biolabs). The TMEFF2-myc-his
fusion construct has been previously described (11). For uORF
analyses, cells were grown to 70–90% confluency in 6-well plates
and transfected with 1.5 mg of each construct per well and the
same amount of the pSeap-Control Vector II (BD Biosciences).
Cells were transfected with Lipofectamine 2000 (Invitrogen)
following the manufacturer’s protocol and using 4 ml/well of
Lipofectamine reagent. Cells and supernatants were collected
24 hrs post-transfection, and luciferase activity was determined
from the supernatants using the BioLux kit (New England Biolabs).
Seap levels were measured using the Great Escape Seap
Chemiluminescence Kit 2.0 (Clontech Laboratories). For both
assays, luminescence was detected using a 20/20n luminometer
(Turner Biosystems).
For DHT-stimulated reporter assays, cells were hormone-
starved for 48 hrs in phenol red-free medium containing 10%
charcoal-stripped serum (CSS) prior to stimulation with DHT.
Twenty-four hours after hormone removal the cells were
transfected using Fugene HD transfection reagent (Promega)
following the manufacturer’s recommendations. Briefly, 10 mg of
Table 1. Primers used for plasmid construction or qRT-PCR
detection.



















*The three-nucleotide mutation introduced is underlined.
doi:10.1371/journal.pone.0055257.t001
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each construct and 10 mg of pSeap2 were diluted in serum-free
RPMI along with 30 ml Fugene HD reagent for a total volume of
500 ml. 100 ml of this transfection mix was added per well of a 6-
well plate. The following day, DHT or ethanol vehicle were added
to fresh CSS-RPMI and the cells were incubated for another
48 hrs prior to harvesting cells and supernatants. To measure
Gaussia luciferase mRNA levels, RNA was isolated from the cells
using the RNAqueous kit (Ambion) following the supplied
protocol. cDNA was then synthesized using the iScript kit (BioRad
Laboratories), and luciferase mRNA levels were measured by
qRT-PCR using IQ SYBR Green Supermix and the IQ5 Real-
Time PCR Detection System (BioRad Laboratories). Luciferase
mRNA levels were normalized to b-actin and gene expression was
analyzed using IQ5 Optical System Software (BioRad Laborato-
ries). See table 1 for primers used for qRT-PCR.
DHT Stimulation Time-course
Cells were hormone-starved in phenol red-free media contain-
ing 10% CSS overnight prior to stimulation with 10 nM DHT or
DMSO control. Actinomycin D was used at a concentration of
5 nM. RNA was isolated from cells using the RNeasy Kit (Qiagen)
and cDNA was synthesized using SuperScript II Reverse
Transcriptase (Invitrogen). TMEFF2 message levels were mea-
sured by qRT-PCR amplification using TaqMan TMEFF2
primers (Hs00249367_m1, Applied Biosystems), and normalized
to GAPDH message levels (amplified with Hs99999905_m1,
Applied Biosystems).
Androgen Receptor Knockdown
AR expression was reduced in 22RV1 cells using the ON-
TARGET plus SMART pool for human AR (Thermo Scientific).
Non-targeting siRNA was included as a control. Briefly, 5 ml of
silencing RNAs and 7.5 ml of DharmaFECT Transfection Re-
agent (Thermo Scientific) were each separately diluted in 300 ml
serum-free, phenol red-free RPMI. After 5 min incubation, the
solutions were combined and incubated for another 20 min at
room temperature, then added to an 85% confluent cell mono-
layer in a T-25 flask containing 2.4 ml of complete, phenol red-
free RPMI.
Immunoblotting
Cell lysates were prepared with RadioImmunoPrecipitation
Assay (RIPA) buffer [25 mM Tris-HCl pH 7.6, 150 mM NaCl,
1% Trition X-100, 1% sodium deoxycholate, 0.1% SDS]
supplemented with 0.1 mM b-glycerophosphate and 0.5 mM
sodium orthovanadate and protease inhibitor cocktail (Sigma).
Twenty mg of lysates were separated on Mini-protean TGX gels
(BioRad) and transferred to PVDF membranes. These were then
blocked for 30 min in 5% NFDM diluted in TBS-T and incubated
with the primary antibody overnight at 4uC. Incubations with
a 1:10,000 dilution of HRP-conjugated secondary antibody (Santa
Cruz Biotechnology) were for 1 hr at room temperature. De-
tection was carried out using SuperSignal West Pico Chemilumi-
nescent Substrate (Thermo Scientific) for 5 min. In some cases,
blots were stripped with Restore PLUS Western Blot Stripping
Buffer (Thermo Scientific) following the manufacturer’s recom-
mendations. Antibodies against TMEFF2, PSA, and eIF2a-P
(Ser51) were from Abcam, eIF2a and CREB2/ATF4 antibodies
were purchased from Santa Cruz Biotechnology, and P-eIF2a
(Ser51) antibodies were from Cell Signaling Technology.
Polysome Analysis
Cell monolayers were washed once with cold 1X PBS and
scraped with lysis buffer [100 mmol/L KCl, 10 mmol/L HEPES
(pH 7.4), 0.5% NP40, 5 mmol/L MgCl2, 100 mg/ml cyclohexi-
mide], and incubated on ice for 10 mins, followed by a 5 min spin
at 10,000 rpm at 4uC to pellet cellular debris. Equal protein
concentrations of cytoplasmic extracts (1.8 mg) were then overlaid
onto a linear sucrose gradient [15–45% (w/v) 10 mmol/L HEPES
(pH 7.4), 100 mmol/L KCl, 5 mmol/L MgCl2] and centrifuged
at 35,000 rpm for 2 hrs at 4uC in an SW41-Ti rotor without the
brake. Using an ISCO UA-6, fractions were collected with
continuous UV monitoring at 254 nm. RNA was isolated from
fractions using Trizol reagent (Ambion). Twenty-five micrograms
of RNA were then used for cDNA synthesis using an iScript kit
(BioRad Laboratories). A sample of 0.1 mg of each cDNA
preparation was used to amplify TMEFF2, ATF4, and b-actin by
PCR using the Platinum Taq HiFi DNA Polymerase system
(Invitrogen). PCR products were then visualized on a 1% agarose
gel and analyzed using the public domain NIH Image J program
(developed at the U.S. National Institutes of Health and available
on the Internet at http://rsb.info.nih.gov/nih-image/).
Immunoflourescence
Cells were plated at a density of 10,000 cells/well in Lab-Tek 8
well chambered slides (Nalge Nunc International) and incubated
overnight in a humidified 37uC incubator with 5% CO2. Cells
were washed in PBS and fixed in 4% paraformaldehyde for 10
minutes, washed in PBS and permeabilized with 0.1% Triton-
X100 in PBS and blocked with 5% normal goat serum in 0.1%
PBST. Samples were incubated for 1 hour with the indicated
primary antibodies. The corresponding secondary antibodies were
added at a 1:500 dilution in 5% goat serum in PBS-T (0.1%
Tween 20): goat anti-rabbit IgG-AF488 (Invitrogen) and goat anti-
mouse IgG-AF488 (Invitrogen). Cells were washed 3 times in PBS-
T (0.1% Tween 20). Slides were air-dried and mounted in medium
containing DAPI.
Subcellular Fractionation
Extracts from cells grown in the presence of 10 nM DHT, or
DMSO as control, were fractionated into cytosolic, membranous,
nuclear and cytoskeletal fractions using the Subcellular Proteome
Extraction kit (Calbiochem).
Statistical Analysis
Data are expressed as mean 6 SD. Differences were analyzed
using paired, two-tailed t-tests. P values #0.05 (*) or #0.01 (**)
were considered significant.
Results
The TMEFF2 59-UTR Contains Several uORFs that Block
Translation of the TMEFF2 Protein
The 59 UTR of the TMEFF2 mRNA contains several potential
uORFs (Figure 1A) that, if translated would potentially block
translation of the TMEFF2 main coding sequence, and therefore
contribute to the regulation of TMEFF2 expression. To investigate
the role of the uORFs in regulating TMEFF2 protein expression,
we asked whether blocking translation of the uORFs would affect
translation of the TMEFF2 protein in human prostate cancer cell
lines. A TMEFF2-Gaussia Luciferase (GLuc) reporter was
generated for this purpose by cloning the TMEFF2 59-UTR,
including four uORFs, upstream of the GLuc sequences
(pTM1234-Gluc; Figure 1B). The TMEFF2-Gluc fusion was
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placed under control of the CMV promoter. The regulatory
contribution of the uORFs to TMEFF2 translation was evaluated
by mutating the start codons (AUGs) of the four potential uORFs
(AUG to GUG, Figure 1B) and determining their effect on GLuc
expression in the androgen-dependent prostate cancer cell line
LNCaP and its bone-metastatic, androgen-independent derivative
C4-2B cell line. A six- to seven-fold increase in Luciferase
expression was observed when the AUGs from all four uORFs
were mutated (pTMXXXX-Gluc; Figure 1C). Single mutations on
the AUGs of the second, third or fourth uORFs promoted a 3–4
fold increase in GLuc expression, while mutating the AUG of the
first uORF had a very small effect, suggesting a minimal role, if
any, in regulation of TMEFF2 expression. Accordingly, combined
mutations of uORFs 2, 3, and 4 resulted in a five- to six-fold
increase in Luciferase expression of the reporter, similar to that
observed when all four uORFs were mutated (Figure 1C). Similar
results were obtained in other androgen-responsive (22Rv1) and -
independent (PC3) prostate cancer cell lines. Mutation of the
uORFs resulted in increased Luciferase expression of the GLuc
reporter, albeit at variable fold induction (Figure 1D). In the
constructs used for these experiments, expression of the fusion
gene was directed by the CMV promoter, and the luciferase
activity was normalized to mRNA levels. Altogether, these results
suggest that the uORFs in the 59- UTR of TMEFF2 mRNA
function synergistically to repress translation of the main
downstream ORF.
Translation of a TMEFF2-Luciferase Reporter is Regulated
by Androgens through a Mechanism that Requires the
Presence of the uORFs in the mRNA Leader Region
Transcription of the tmeff2 gene is regulated by androgens [8].
However, it has been suggested that androgens also affect
TMEFF2 expression at the post-transcriptional level [10], prompt-
ing us to examine whether TMEFF2 translation was affected by
androgens. 22Rv1 cells were selected for these experiments since:
i) they have been shown to be a valuable model for AR-mediated
reporter gene assays [18], ii) they demonstrated the highest fold
increase in Luciferase reporter gene expression when the uORFs
were mutated (see Figure 1D), and iii) they express detectable
levels of endogenous TMEFF2 protein. 22Rv1 cells were
transfected with the pTM1234-Gluc reporter, grown in phenol
red-free media supplemented with charcoal-stripped (CS) FBS – to
remove steroid hormones- and treated with different concentra-
tions of dihydrotestosterone (DHT). Luciferase activity was
measured from the supernatants and normalized to mRNA levels.
Addition of DHT increased Luciferase expression in a dose-
dependent manner (Figure 2A), indicating that androgens
stimulate the translation of the main ORF. Importantly, this
effect was observed at DHT concentrations within the physiolog-
ical levels found in human serum [19]. Luciferase activity from
cells carrying the pTMXXXX-Gluc reporter construct, in which
the AUGs from all four uORFs were mutated, did not change in
response to DHT, although, as expected, was much higher
(Figure 2A). These results indicate that translation of the main
ORF downstream of the TMEFF2 59- UTR is regulated by
androgens in an uORF-dependent manner.
To determine whether the DHT effect on translation is
mediated by the AR, the experiments described above were
repeated in the presence of bicalutamide to block AR activation.
Addition of this drug reduced the DHT-mediated induction of the
pTM1234-Gluc reporter Luciferase expression to near basal levels,
although a small two- to three-fold induction could be observed at
10 nM DHT (Figure 2B). These results indicate that the effect of
DHT on translation of the reporter construct requires AR
signaling. In agreement with these results, we did not observe
DHT-induced translation of the pTM1234-Gluc reporter in PC3
prostate cancer cells that do not express the AR (Figure 2C).
Altogether, these results indicate that DHT-induced translation of
TMEFF2 requires activation of the AR and is mediated by the
uORFs in the leader region of the mRNA.
Translation of the Endogenous TMEFF2 Protein is
Regulated by Androgens
Changes in the expression of the endogenous TMEFF2 protein
in response to androgens were also analyzed. For this purpose,
22Rv1 cells were grown in phenol red-free media supplemented
with CS-FBS treated with different concentrations of DHT, and
lysates analyzed for TMEFF2 expression by western blotting. In
the absence of androgens, expression of TMEFF2 was barely
detectable. However, addition of DHT increased TMEFF2
expression (Figure 3A), and resulted in the highest levels within
the range of physiological DHT concentrations. DHT-induced
expression of endogenous TMEFF2 was also observed in the
androgen-responsive prostate cancer LNCaP cells (Figure 3A).
The expression of prostate specific androgen (PSA), an AR target
used as control for androgen transcriptional activity, was enhanced
by the addition of DHT (Figure 3A). Treatment of the cells with
bicalutamide notably inhibited DHT-induced TMEFF2 and PSA
expression that was only observed at the highest concentrations of
DHT (Figure 3A). Inhibition of DHT-induced TMEFF2 expres-
sion was also achieved after knocking down expression of the AR
using siRNA (Figure 3B). Altogether, these results indicate that the
expression of the endogenous TMEFF2 protein is regulated by AR
signaling.
We observed an increase in TMEFF2 mRNA levels in response
to DHT as measured by qRT-PCR (Figure 3C), consistent with
a previous report indicating that androgens stimulate tmeff2
transcription [8]. However, the modest increase in mRNA levels
does not likely explain the observed DHT-mediated increase in
protein expression. To rule out the possibility that the increase in
endogenous TMEFF2 protein observed in response to DHT was
solely due to increased transcription, we used actinomycin D to
block transcription and assessed the levels of TMEFF2 protein and
mRNA in 22Rv1 cells at different time points after the addition of
DHT, to induce tmeff2 expression, and/or actinomycin D.
TMEFF2 protein levels increased dramatically 60–120 mins after
the addition of DHT, but not DMSO, the vehicle control
(Figure 4A). Importantly, in the presence of actinomycin D,
addition of DHT still promoted an increase in TMEFF2 protein
expression, albeit at a lower level than observed in the absence of
the transcription inhibitor. As indicated by analysis of the
TMEFF2 mRNA levels by qRT-PCR, addition of actinomycin
D inhibited basal and DHT-induced tmeff2 transcription
(Figure 4B). Addition of DHT alone promoted a slight initial
increase in transcription (1.2-fold after 20 mins) that progressively
declined to basal levels after 60 mins of treatment (not shown).
Therefore, these results reveal that androgens regulate not only
transcription of the tmeff2 gene but also translation of the
endogenous TMEFF2 mRNA, supporting the results presented
above using a TMEFF2-Luciferase reporter.
Other proteins including b-catenin and occludin translocate to
the nucleus or regions of cellular contact after androgen treatment.
However, our results indicated that androgen treatment did not
alter the subcellular localization of TMEFF2 (Figure S1).
Androgen Signaling Promotes eIF2a Phosphorylation
Phosphorylation of eIF2a reduces global translation but also
provides a mechanism that selectively enhances translation of
Androgens Regulate TMEFF2 Translation via eIF2a-P
PLOS ONE | www.plosone.org 4 February 2013 | Volume 8 | Issue 2 | e55257
uORF-containing mRNAs [13,20]. We therefore hypothesized
that DHT promotes endogenous TMEFF2 translation through
phosphorylation of eIF2a. The effect of DHT on eIF2a
phosphorylation was examined by western blot analysis in prostate
cancer 22Rv1 and PC3 cells grown in phenol red-free media
supplemented with CS-FBS and treated with different concentra-
tions of DHT. Increased levels of eIF2a-P were clearly detected, in
a dose-dependent manner, in lysates from DHT-treated 22Rv1
cells but not in lysates from DHT-treated AR-null PC3 cells
(Figure 5A), indicating that androgens promote eIF2a-P and that
this effect is dependent on the presence of a functional AR. In
agreement with these results, pretreatment of the 22Rv1 cells with
the AR antagonist bicalutamide prevented DHT-mediated in-
creases in eIF2a phosphorylation (Figure 5B). DHT addition also
promoted an increase in the expression of the ATF4 protein,
a transcription factor regulated by eIF2a phosphorylation
(Figure 5A).
Conditions that Promote eIF2a-P Result in Increased
TMEFF2 Translation
In order to determine whether eIF2a phosphorylation is
sufficient to regulate translation of TMEFF2, 22Rv1 cells were
treated with clotrimazole, a drug that causes depletion of
intracellular Ca2+ stores, resulting in activation of the PKR kinase
and subsequent eIF2a-P, and the effect on TMEFF2 translation
efficiency was analyzed using polysome analysis. Western blot
analyses indicated that the clotrimazole treatment resulted in
increased phosphorylation of eIF2a in 22Rv1 cells (Figure 6A). As
previously described [21,22], clotrimazole treatment resulted in
reduced polysomes along with an increase in monosomes in-
dicating inhibition of translation initiation (Figure 6B). Under
Figure 1. The uORFs in the 59-UTR of TMEFF2 inhibit translation of the main coding region. A) Schematic representation of 394 nt
upstream of the TMEFF2 main coding region and relative localization of four potential uORFs (aa = amino acid) within the 59-UTR. B) Schematic
representation of the TMEFF2-Gaussia Luciferase reporter and mutant constructs. The X indicates mutation of the AUG to a GUG to prevent
translation of the mutated uORFs. Single and multiple mutations were introduced. C) luciferase activity demonstrated by the pTM1234-Gluc and the
different mutant constructs in LNCaP and C4-2 cells. D) Luciferase activity demonstrated by the pTM1234-Gluc and the construct with all the uORFs
mutated (pTMXXXX-Gluc) in PC3 and 22Rv1 cells. In C) and D) luciferase activity was measured in the supernatant and calculated by first normalizing
to mRNA levels for each construct and then to the luciferase activity demonstrated by the pTM1234-Gluc reporter construct, which does not have
mutations in the uORFs, considered arbitrarily as 1. Data shown are mean 6 S.D. of at least two independent experiments with multiple replicates. *,
p,0.05, and **, p,0.01.
doi:10.1371/journal.pone.0055257.g001
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these conditions, we observed a shift of the TMEFF2 mRNA
towards the heavier polysomal fractions when compared to the
DMSO-treated controls (Figures 6B and 6C), suggesting that
clotrimazole treatment increased translation of the TMEFF2
mRNA. However, the shift was small, likely reflecting the presence
of multiple uORFs and a complex translational regulatory
mechanism. Similar results were observed in other cell lines (data
not shown). Confirming these results, clotrimazole treatment of
cells containing the pTM1234-Gluc reporter resulted in a signif-
icant increase in luciferase activity (data not shown). In addition,
a shift to the heavier polysomal fractions was also observed for the
uORF-containing ATF4 mRNA, known to be preferentially
translated upon eIF2a-P (Figures 6B and 6C; [23]). Taken
together, these results demonstrate that eIF2a phosphorylation,
independent of the causative stimulus, is sufficient to enhance
translation of TMEFF2.
eIF2a Phosphorylation is Essential for Increased
Translation of a TMEFF2-GLuc Reporter in Response to ER
Stress
To further investigate the role of eIF2a phosphorylation on
translation of TMEFF2, mouse embryonic fibroblasts (MEFs)
expressing either wild-type eIF2a (S/S) or an eIF2a S51A (A/A)
mutant form, carrying a Ser to Ala mutation that prevents
phosphorylation of eIF2a, were transfected with the pTM1234-
Gluc reporter and expression of the reporter analyzed after
addition of thapsigargin, a drug that disrupts ER calcium
homeostasis leading to kinase activation and eIF2a phosphoryla-
tion. This experimental system was tested by treating the cells with
clotrimazole or thapsigargin and determining that both drugs
effectively promoted eIF2a-P in cells carrying the wild-type but
not the S51A (A/A) mutant eIF2a (Figure 7A). Since thapsigargin
demonstrated a more robust response, it was chosen for sub-
sequent experiments. MEFs expressing the pTM1234-Gluc re-
porter were grown in phenol red-free media supplemented with
CS-FBS in the absence or presence of different concentrations of
thapsigargin. Increased luciferase activity from the pTM1234-
Figure 2. DHT promotes AR-mediated increased translation of the TMEFF2-GLuc fusion protein in 22Rv1 prostate cancer cells. A)
Luciferase activity demonstrated by the pTM1234-Gluc and the pTMXXXX-Gluc mutant construct in 22Rv1 cells in the presence of different
concentrations of DHT. B) Luciferase activity demonstrated by the pTM1234-Gluc construct in 22Rv1 cells in the presence of different concentrations
of DHT and DHT +20 mM bicalutamide (bic), an AR agonist. C) Luciferase activity demonstrated by the pTM1234-Gluc construct in PC3 cells in the
presence of different concentrations of DHT. For all these experiments cells were hormone-starved in phenol red-free media containing charcoal
stripped serum. Luciferase activity was normalized to mRNA levels for each construct and then to the luciferase activity demonstrated by each one of
the constructs expressed in cells grown in the absence of DHT, which was set to 1. Data shown are mean 6 S.D. of at least three independent
experiments with multiple replicates. *, p,0.05, and **, p,0.01.
doi:10.1371/journal.pone.0055257.g002
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Gluc reporter was detected in response to 0.1 and 0.5 mM
thapsigargin in cells carrying the wild-type eIF2a but not in the
eIF2a S51A mutant cells (Figure 7B). Higher concentrations of
thapsigargin did not result in higher luciferase activity and reached
a toxic level (data not shown). Similarly, thapsigargin was able to
increase ATF4 protein levels used as a positive control for eIF2a
Figure 3. DHT promotes AR-mediated increased expression of the endogenous TMEFF2 protein in prostate cancer cells. A)
Representative western blots indicating an increase in TMEFF2 expression in response to DHT addition in 22Rv1 and LNCaP cells (a= antibody).
Simultaneous addition of 20 mM bicalutamide to 22Rv1 cells (middle panel) prevented the increase in TMEFF2 expression observed at physiological
concentration of DHT. PSA was used as positive control since its expression is induced by androgen in an AR-dependent manner. b-tubulin was used
as a loading control. B) Western blot indicating effective knock down of the two forms of the AR in 22Rv1 cells using siRNA (right). Representative
western blot indicating that addition of DHT has no effect on the expression of TMEFF2 in cells in which AR levels were reduced by RNAi. PSA was
used as control and, as expected, its expression was not affected by DHT in the AR-siRNA treated cells. b-tubulin was used as a loading control. C)
Changes in TMEFF2 mRNA levels in LNCaP and 22Rv1 cell lines in response to DHT as measured by qRT-PCR. Values were normalized to b-tubulin
mRNA. Each experiment was repeated at least three times and, for the representative images presented, the membranes were stripped and re-
probed with the different antibodies or the same samples were re-run in a different gel. b-tubulin was used as a loading control each time the
samples were run.
doi:10.1371/journal.pone.0055257.g003
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phosphorylation, only in the cells carrying the wild-type eIF2a
allele (Figure 7C). These results confirm that phosphorylation of
eIF2a is required to induce translation of the TMEFF2-Gluc
reporter observed in response to ER stress.
Discussion
Changes in the expression of TMEFF2 protein have been
documented in prostate cancer, and a potential role for TMEFF2
in this disease has been proposed [7–11]. However, the molecular
mechanisms leading to deregulation of TMEFF2 expression in
prostate cancer are not known. The present study reveals a novel
role for androgens in the regulation of TMEFF2 translation that
could account for the changes in TMEFF2 expression observed in
prostate cancer. We demonstrate that androgen signaling
promotes increased TMEFF2 mRNA translation through a mech-
anism that involves phosphorylation of eIF2a and is dependent on
the presence of uORFs in the 59-UTR of the TMEFF2 mRNA.
The main androgen, testosterone, and its metabolite, DHT,
largely mediate their effect through binding to the AR, a ligand-
inducible transcription factor. The bound AR can then recognize
and bind specific androgen response elements in the promoter
regions of target genes, causing activation or repression of
transcription, leading to subsequent changes in protein synthesis
Figure 4. DHT promotes increased transcription and translation of the endogenous tmeff2 gene. A) Representative western blot
demonstrating the TMEFF2 protein at the indicated time points after addition of 10 nM DHT in the presence or absence of 5 nM actinomycin D (Act
D) to block transcription. Either DMSO or DHT and actinomycin D were added simultaneously. Quantitation of the blots is presented below the
western blot. The band intensities of the samples treated with DHT were normalized first to b-tubulin and then to the values obtained for the DMSO
samples at the corresponding time points. B) Changes in TMEFF2 mRNA levels in 22Rv1 cells in response to DHT or DMSO and actinomycin D
treatment as measured by qRT-PCR. Values were normalized to GAPDH. Data shown are representative of two independent experiments.
doi:10.1371/journal.pone.0055257.g004
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[24]. However, post-transcriptional regulation of gene expression
by androgens has also been documented, affecting mRNA
stability, protein localization, polyA-tail length, and translation
efficiency [25–27]. The effect of androgens on translation is
mediated through several mechanisms including changes in
miRNA expression or processing [28–30], phosphorylation of
translation factors like eEF2 [31], or mTOR activation-mediated
phosphorylation of p70S6 and 4E-BP1 [32]. The results presented
here indicate that physiological concentrations of DHT promote
eIF2a phosphorylation in prostate cancer cell lines to influence
translation.
Phosphorylation of eIF2a ultimately leads to inhibition of global
translation initiation along with stimulation of translation of
specific mRNAs, i.e. uORF-containing mRNAs. These changes
facilitate cellular adaptation to the stress conditions promoting
either survival or initiation of apoptosis [33]. Using TMEFF2-
Luciferase reporter constructs in which the 59-UTR of TMEFF2
was fused to the Gaussia luciferase gene, we demonstrated that, in
addition to phosphorylating eIF2a, DHT also promotes trans-
lation of TMEFF2. Importantly, this effect requires the presence of
uORFs in the 59-UTR of the TMEFF2 mRNA, as DHT showed
no effect on translation of a TMEFF2-Luciferase reporter in which
the AUGs for each of the uORFs were mutated. Supporting these
results, translation of the TMEFF2 endogenous protein and the
uORF-containing ATF4 transcriptional regulator, (known to be
regulated by eIF2a-P) were also increased in response to DHT
stimulation. Moreover, as previously demonstrated for ATF4 [34],
polysome analysis revealed that translation efficiency of TMEFF2
increased in response to clotrimazole, a translation inhibitor that
promotes ER stress and subsequent eIF2a-P. In addition, the
DHT effect on TMEFF2 translation was not observed in cells
carrying a non-phosphorylatable form of eIF2a. These results
suggest that the effect of DHT in TMEFF2 protein expression was
mediated by eIF2a-P. We also demonstrated that the DHT effect
on TMEFF2 protein expression required the presence of
a functional AR, but was partially independent of transcriptional
activity. To our knowledge, this is the first report demonstrating
a transcription-independent effect of DHT on translation of
uORF-containing mRNAs through phosphorylation of eIF2a.
Phosphorylation of eIF2a in response to different forms of stress
is mediated by one of the following four kinases [35]: protein
kinase R (PKR), heme-regulated eIF2a kinase (HRI), protein
kinase R-like kinase (PERK), or GCN2 (general control nonder-
epressible-2). Several different kinases might be responsible for
eIF2a phosphorylation in response to DHT. Androgens regulate
transcription of many genes, including some of those involved in
amino acid metabolism [26,36,37], and it is therefore possible that
DHT-induced eIF2a phosphorylation results from GCN2 activa-
tion driven by metabolic changes. However, under our experi-
mental conditions, DHT stimulated translation of TMEFF2 in the
presence of actinomycin D, suggesting that the DHT-induced
phosphorylation of eIF2a is, at least partly non-genomic. While
Figure 5. DHT induces phosphorylation of eIF2a in an AR-dependent manner. A) Representative western blots indicating an increase in
eIF2a-P in response to DHT addition in 22Rv1 cells. This effect was abrogated in PC3 cells, which do not express AR (right). ATF4 protein levels were
measured as a positive control since it is induced by eIF2a-P. b-actin was used as a loading control. B) Addition of 20 mM bicalutamide to 22Rv1 cells
prevented the increase in eIF2a-P observed after addition of DHT. b-tubulin or b-actin were used as loading controls. C) Densitometry of the western
blot bands from A) and B). The ratio of eIF2a-P to total eIF2a for each specific cell line/treatment is graphed to determine the changes in eIF2a-P
promoted by DHT treatment.
doi:10.1371/journal.pone.0055257.g005
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this manuscript was in preparation, Dai and collaborators [38]
reported increased apoptosis of human liver cells in response to
DHT administration through a PKR-eIF2a-P dependent mech-
anism. This effect was sensitive to the AR antagonist flutamide and
it seemed to involve CHOP (GADD153) activation. These results
suggest that DHT functions by activating PKR, however, the
experiments were performed in the presence of 100 nM DHT,
a concentration much higher than physiological levels (1–10 nM).
In this regard, studies in mice indicate that excess androgens can
promote oxidative stress [39–42], which can induce PKR activity
[43] and phosphorylation of eIF2a. In cell lines, addition of
physiological levels of DHT can promote increased cytosolic
calcium (Ca2+), which can promote PKR activation either directly
or indirectly by increasing oxidative stress [44–46]. Therefore,
DHT could indirectly promote PKR activation through its ability
to promote accumulation of intracellular calcium, a well-known
transcription independent, non-genomic effect of androgen.
TMEFF2 is mainly expressed in the adult brain and prostate
where it plays a role as a tumor suppressor [7–9,11,47]. In these
two tissues, androgens/AR signaling are known to regulate the
frequency and extent of male typical behaviors [48] and the
development, function, and homeostasis of the prostate as well as
prostate cancer initiation and progression [49], respectively.
Interestingly, basal TMEFF2 protein expression has been reported
in other tissues such as mouse white adipose tissue [50] and rat
heart and kidney ([51]; see also human data available in the gene
expression Atlas), in which the role of androgen/AR signaling is
not clear. However, in these tissues, the presence of the AR has
been thoroughly described and some effects of androgens have
been reported [52–56]. Therefore, although not yet explored, it is
possible that expression of TMEFF2 in these tissues is also
regulated by androgen signaling.
What is the role of AR-mediated phosphorylation of eIF2a in
prostate cancer? A correlation between translation initiation and
prostate cancer can be postulated from the observation that several
translation initiation factors are overexpressed or activated in this
disease [57]. For example, eIF3h and eIF4E are frequently
overexpressed in advanced prostate cancers, together with in-
creased phosphorylation of eIF4E and eIF4E-BP1, which support
increased translation [58]. However, the role of eIF2a-P in
Figure 6. TMEFF2 mRNA associates with heavier polysomes in response to ER stress. A) Western blot indicating phosphorylation of eIF2a
in response to ER-stress inducing agents in 22Rv1 cells. B) 22Rv1 cells were exposed to 15 mM clotrimazole (CLT) or vehicle control (DMSO) for 1 hr
and lysates subjected to polysome analysis. A representative example of one of the three independent polysome profiles obtained is shown. C) Total
RNA was prepared from the fractions, and the percentage of TMEFF2, ATF4, and b-actinmRNAs present in each fraction were determined by qRT-PCR.
Results from one of three independent experiments are shown.
doi:10.1371/journal.pone.0055257.g006
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prostate or other cancers is not clear. While expression of a non-
phosphorylatable form of eIF2a or overexpression of a dominant-
negative form of PKR have been shown to inhibit apoptosis and
cause malignant transformation, other reports indicated that
reduced PKR levels correlated with less aggressive tumors [58]. In
general, it has been suggested that the role of eIF2a-P is dependent
on the stage and grade of the disease, occurring at the earliest
stages as a response to stress, while downregulation of eIF2a-P will
occur later on as a result of the selective pressure imposed by the
tumor’s cell need to proliferate [57]. Androgen signaling is critical
for the progression of prostate cancer, and changes in the
sensitivity to androgen signaling after prostate cancer regression
drives the cancer to the advanced stages. It is possible that early in
prostate cancer, or upon recurrence, androgen signaling triggers
PKR activation and subsequent eIF2a-P, leading to anti-pro-
liferative effects, apoptosis, and the activation of tumor suppressor
mechanisms. In this respect, it has been reported that the
antiproliferative and pro-apoptotic effects of PTEN, a tumor
suppressor protein frequently mutated in prostate cancer, require
activation of the PKR-eIF2a-P pathway [59]. Persistent AR
signaling along with dowregulation of eIF2a-P may lead to AR-
mediated transcriptional events and tumor progression. Interest-
ingly, while the relative contribution of androgen-dependent
transcriptional and translational mechanisms to the regulation of
TMEFF2 expression cannot be accurately determined from our
studies, previous prostate cancer xenograft data demonstrated that
TMEFF2 protein, but not mRNA, levels were increased in
recurrent tumors and in tumors obtained from 6-day castrate mice
treated with testosterone [10], and correlate with the expression of
androgen receptor [60]. These results suggest that translational
control by AR signaling may play an important role on TMEFF2
regulation during the transition to castration resistant prostate
cancer.
In summary, our findings reveal a novel role for AR signaling as
a translational regulator of TMEFF2 through phosphorylation of
eIF2a. We have previously demonstrated that the tumor
suppressor ability of TMEFF2 partly correlates with its ability to
interact with SARDH and modulate the levels of sarcosine [11].
SARDH and GNMT, the enzymes that catalyze the forward and
reverse conversion of sarcosine into glycine, are under transcrip-
Figure 7. Phosphorylation of eIF2a is required for increased TMEFF2 translation in response to ER stress. A)Mouse embryonic fibroblast
(MEF) cells expressing the wild type (S/S) or mutant (Ser51 to Ala; A/A) eIF2 proteins were treated with the indicated concentrations of clotrimazole
(CLT) or thapsigargin (TG) and protein lysates from these cells were analyzed by western blot to determine the extent of eIF2a-P. Total eIF2a was used
as loading control. B) Luciferase activity demonstrated by the pTM1234-Gluc reporter construct in wt (S/S) or mutant (A/A) MEFs in the absence or
presence of the indicated concentrations of thapsigargin. Luciferase activity was normalized to the luciferase activity of the reporter expressed in cells
grown in the absence of thapsigargin, which was set to 1. Data shown are mean 6 S.D. of at least three independent experiments with multiple
replicates. *, p,0.05, and **, p,0.01. C) Western blot analysis demonstrating increased ATF4 expression as a result of thapsigargin treatment in MEF
cells carrying the wt form of the eIF2a subunit (MEF S/S) but not the mutant form mutant (MEF A/A). b-tubulin was used as a loading control.
doi:10.1371/journal.pone.0055257.g007
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tional control mediated by the androgen receptor. Treatment of
prostate cancer cell lines with androgens resulted in an increase in
GNMT expression and a simultaneous decrease in SARDH levels
[12]. Since tmeff2 is both transcriptionally [8] and translationally
regulated by androgens, these observations potentially link
androgens with the regulation of sarcosine metabolism and
changes in TMEFF2 expression, and may suggest a model by
which in the early stages of tumorigenesis the increased expression
of TMEFF2 in response to androgens is a cellular response to
overcome tumorigenesis. Persistent AR signaling leads to an
increase in GNMT and a simultaneous decrease in SARDH
expression that overcome the effect of increased TMEFF2 levels.
Therefore, TMEFF2 upregulation in response to AR signaling
may initially serve as a barrier for malignant progression of
prostate cancer.
Genomic, proteomic and metabolomic studies have implicated
androgens/AR signaling in regulating metabolic processes in
prostate cancer. Relevant to our studies, recent data from the
Sreekumar laboratory uncovered a role for androgens in activating
amino acid metabolism and methylation in prostate cancer cells
[61]. Since sarcosine, SARDH, GNMT and TMEFF2, are
directly involved in 1-carbon metabolism and therefore S-
adenosylmethionine utilization, it is possible that AR exerts its
effect on methylation at least in part by modulating the enzymes
involved in the sarcosine-related steps in the pathway. Interest-
ingly, AR expression, activity and function are methylation-
dependent [62–65], suggesting a potential feed-forward mecha-
nism by which AR increases TMEFF2 expression leading to
changes in the methylation potential of the cell that consequently
affects AR function. A potential direct effect of TMEFF2 on AR
function is currently under investigation.
Supporting Information
Figure S1 DHT does not alter the subcellular localiza-
tion of TMEFF2. The potential effect of DHT on TMEFF2
localization was examined by subcellular fractionation (A) or
immunofluorescence (B). A) 22Rv1 cells were treated with DHT
or the vehicle control and subcellular fractions separated and
analyzed by western blot using a TMEFF2 antibody. B) TMEFF2
localization was analyzed in cells treated with DHT, or DMSO as
a control, using confocal microscopy. Fixed 22Rv1 cells expressing
endogenous TMEFF2 (green) were analyzed using a TMEFF2
antibody while RWPE1 cells transfected with a TMEFF2-myc-his
tagged protein were analyzed using an anti-c-myc antibody.
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